Clinical Trials for Agitation

Find clinical trials for agitation. Discover research opportunities and treatment options in your area.

14 Active Trials Found

Showing 14 trials on this page

Page 1 of 1

Detection of Risk Behaviors: Pilot Observational Study With Bedridden and Agitated Patients.

NCT ID: NCT05522647

This clinical trial is studying how often and what kinds of risky behaviors happen in patients who are bedridden and agitated while staying in the hospital, especially those with brain injuries. Th...

Recruiting

Type: observational Locations: Clermont Ferrand, , France

Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

NCT ID: NCT06808984

This clinical trial is looking at a new medication called BMS-986368, which aims to help reduce agitation in people with Alzheimer's disease. Agitation can include feelings of restlessness, irritab...

Recruiting

Phase: PHASE2 Type: interventional Locations: Honolulu, Hawaii, United States, La Jolla, California, United States +50 more

Life's End Benefits of cannaBidiol and tetrahYdrocannabinol

NCT ID: NCT05644262

This clinical trial, titled "Life's End Benefits of cannaBidiol and tetrahYdrocannabinol," is exploring whether a combination of two compounds from cannabis—THC (tetrahydrocannabinol) and CBD (cann...

Recruiting

Phase: PHASE2 Type: interventional Locations: Pittsburgh, Pennsylvania, United States, Tampa, Florida, United States +21 more

Responsive Nature-Driven Imagery to Reduce Delirium After Cardiac Surgery

NCT ID: NCT07051096

This clinical trial is studying a new device called MindfulGarden, which shows calming nature images that respond to a patient’s behavior. The goal is to see if using this device after heart surger...

Not yet recruiting

Phase: NA Type: interventional Locations: Vancouver, British Columbia, Canada

A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)

NCT ID: NCT06937229

The ADAGIO-3 study is a clinical trial focused on testing a new treatment for agitation in people with Alzheimer’s Disease. This trial will specifically look at the long-term effects and safety of ...

Not yet recruiting

Phase: PHASE3 Type: interventional Locations: Athens, , Greece, Malaga, , Spain +197 more

Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type

NCT ID: NCT05397639

This clinical trial is studying a medication called masupirdine to see if it can help reduce agitation in people with Alzheimer's disease. Agitation can include symptoms like restlessness, irritabi...

Recruiting

Phase: PHASE3 Type: interventional Locations: Houston, Texas, United States, Amherst, New York, United States +65 more

Comparison of Haloperidol and Dexmedetomidine for Delirium and Agitation in ICU Patients With Traumatic Brain Injury

NCT ID: NCT06993194

This clinical trial is examining the effects of two different medications, haloperidol and dexmedetomidine, to help manage delirium and agitation in patients who have suffered a traumatic brain inj...

Not yet recruiting

Phase: NA Type: interventional

Nabilone for Agitation Blinded Intervention Trial

NCT ID: NCT04516057

This clinical trial is studying whether a medication called nabilone can help reduce agitation in people with Alzheimer's disease (AD). Agitation is a common and difficult-to-treat symptom in AD th...

Recruiting

Phase: PHASE3 Type: interventional Locations: Calgary, Alberta, Canada, Toronto, Ontario, Canada +4 more

Acute Agitation in Emergency Psychiatry

NCT ID: NCT06752616

This clinical trial is focused on finding better ways to treat patients who are experiencing severe agitation in emergency psychiatric settings, like psychiatric emergency rooms. The research team ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Copenhagen N, , Denmark

Neurosteer Bedside Monitoring System

NCT ID: NCT06718764

This clinical trial is studying a new brain monitoring device called the Neurosteer Bedside Monitoring System. The aim is to see how well this device can help doctors monitor patients in the Intens...

Recruiting

Phase: NA Type: interventional Locations: New York, New York, United States

A Music-Based Mobile App for People Living With Alzheimer's Disease and Related Dementias (ADRD)

NCT ID: NCT06140342

This clinical trial is testing a new mobile app designed to help people living with Alzheimer's disease and related dementias. The app aims to recognize signs of agitation, restlessness, or depress...

Recruiting

Type: observational Locations: Brooklyn, New York, United States

Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's Type

NCT ID: NCT06052254

This clinical trial is studying a new treatment called Dexmedetomidine Transdermal Systems (DMTS) to see if it can help reduce agitation in people with Alzheimer's disease. Agitation can be a chall...

Not yet recruiting

Phase: PHASE2 Type: interventional

Premature Enhanced Automated Capture of Comfort Knowledge

NCT ID: NCT06037629

This clinical trial is studying ways to better monitor the comfort levels of preterm infants in hospitals. The goal is to find methods that can help healthcare providers understand how these babies...

Recruiting

Type: observational Locations: Newcastle Upon Tyne, , United Kingdom

Pilot Study 1: Efficacy and Safety of Sublingual Dexmedetomidine (BXCL501) for the Treatment of Agitation in the Emergency Department

NCT ID: NCT05974527

This clinical trial is looking at a medication called BXCL501, which is a type of film that dissolves under the tongue, to see if it can help reduce agitation in patients who come to the emergency ...

Not yet recruiting

Phase: PHASE4 Type: interventional

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions